OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide

Table of Contents

CHAPTER 1 INTRODUCTION

• 1.1 What is this report about?
• 1.2 Who is the target reader?
• 1.3 How to use this report
• 1.4 Definitions

CHAPTER 2 BRIC OTC PHARMACEUTICALS INDUSTRY OUTLOOK

CHAPTER 3 OTC PHARMACEUTICALS IN BRAZIL

• 3.1 Market Overview
• 3.2 Market Value
• 3.3 Market Segmentation I
• 3.4 Market Segmentation II
• 3.5 Market Share
• 3.6 Five Forces Analysis
• 3.7 Leading Companies
• 3.8 Distribution
• 3.9 Market Forecasts
• 3.10 Macroeconomic Indicators

CHAPTER 4 OTC PHARMACEUTICALS IN RUSSIA

• 4.1 Market Overview
• 4.2 Market Value
• 4.3 Market Segmentation I
• 4.4 Market Segmentation II
• 4.5 Market Share
• 4.6 Five Forces Analysis
• 4.7 Leading Companies
• 4.8 Distribution
• 4.9 Market Forecasts
• 4.10 Macroeconomic Indicators

CHAPTER 5 OTC PHARMACEUTICALS IN INDIA

• 5.1 Market Overview
• 5.2 Market Value
• 5.3 Market Segmentation I
• 5.4 Market Segmentation II
• 5.5 Market Share
• 5.6 Five Forces Analysis
• 5.7 Leading Companies
• 5.8 Distribution
• 5.9 Market Forecasts
• 5.10 Macroeconomic Indicators

CHAPTER 6 OTC PHARMACEUTICALS IN CHINA

• 6.1 Market Overview
• 6.2 Market Value
• 6.3 Market Segmentation I
• 6.4 Market Segmentation II
• 6.5 Market Share
• 6.6 Five Forces Analysis
• 6.7 Leading Companies
• 6.8 Distribution
• 6.9 Market Forecasts
• 6.10 Macroeconomic Indicators

CHAPTER 7 APPENDIX

• 7.1 Data Research Methodology

LIST OF TABLES

• Table 1: OTC Pharmaceuticals Industry, BRIC, Revenue ($) 2004-2013 13
• Table 2: OTC Pharmaceuticals Industry, BRIC, Revenue ($ bn) 2004-2008(e) 14
• Table 3: OTC Pharmaceuticals Industry, BRIC, Revenue ($ billion) 2008-2013 15
• Table 4: Brazil OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 17
• Table 5: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 18
• Table 6: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 19
• Table 7: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2007 20
• Table 8: Key Facts: Abbott Laboratories 28
• Table 9: Key Facts: Novartis AG 31
• Table 10: Key Financials: Novartis AG 33
• Table 11: Key Facts: GlaxoSmithKline PLC 34
• Table 12: Key Financials: GlaxoSmithKline PLC 37
• Table 13: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 38
• Table 14: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 39
• Table 15: Brazil Size of Population (million) , 2004-2008(e) 40
• Table 16: Brazil GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 40
• Table 17: Brazil Inflation, 2004-2008(e) 41
• Table 18: Brazil Exchange Rate, 2004-2008(e) 41
• Table 19: Russia OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 43
• Table 20: Russia OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 44
• Table 21: Russia OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 45
• Table 22: Russia OTC Pharmaceuticals Market Share: % Share, by Value, 2007 46
• Table 23: Key Facts: Ranbaxy Laboratories Limited 53
• Table 24: Key Financials: Ranbaxy Laboratories Limited 54
• Table 25: Key Facts: Zentiva NV 55
• Table 26: Key Financials: Zentiva NV 56
• Table 27: Key Facts: KRKA 57
• Table 28: Russia OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 59
• Table 29: Russia OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 60
• Table 30: Russia Size of Population (million) , 2004-2008(e) 61
• Table 31: Russia GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 61
• Table 32: Russia Inflation, 2004-2008(e) 62
• Table 33: Russia Exchange Rate, 2004-2008(e) 62
• Table 34: India OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 64
• Table 35: India OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 65
• Table 36: India OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 66
• Table 37: India OTC Pharmaceuticals Market Share: % Share, by Value, 2007 67
• Table 38: Key Facts: Dabur India Limited 75
• Table 39: Key Financials: Dabur India Limited 77
• Table 40: Key Facts: Zandu Pharmaceutical Works Ltd 78
• Table 41: Key Financials: Zandu Pharmaceutical Works Ltd 79
• Table 42: Key Facts: Cipla Ltd 80
• Table 43: Key Financials: Cipla Ltd 81
• Table 44: India OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 82
• Table 45: India OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 83
• Table 46: India Size of Population (million) , 2004-2008(e) 84
• Table 47: India GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 84
• Table 48: India Inflation, 2004-2008(e) 85
• Table 49: India Exchange Rate, 2004-2008(e) 85
• Table 50: China OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 87
• Table 51: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 88
• Table 52: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 89
• Table 53: China OTC Pharmaceuticals Market Share: % Share, by Value, 2007 90
• Table 54: Key Facts: Nin Jiom Medicine Manufactory Limited 97
• Table 55: Key Facts: Huangshan Tianmu Pharmaceutical Co., Ltd 98
• Table 56: Key Facts: Johnson & Johnson 99
• Table 57: Key Financials: Johnson & Johnson 101
• Table 58: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 102
• Table 59: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 103
• Table 60: China Size of Population (million) , 2004-2008(e) 104
• Table 61: China GDP (Constant 2000 Prices, $ billion), 2004-2008(e) 104
• Table 62: China Inflation, 2004-2008(e) 105
• Table 63: China Exchange Rate, 2004-2008(e) 105

LIST OF FIGURES

• Figure 1: OTC Pharmaceuticals Industry, BRIC, Revenue ($ bn) 2004-2013 13
• Figure 2: OTC Pharmaceuticals Industry, BRIC, Revenue ($ bn) 2004-2008(e) 14
• Figure 3: OTC Pharmaceuticals Industry, BRIC, Revenue ($) 2008-2013 15
• Figure 4: Brazil OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 17
• Figure 5: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 18
• Figure 6: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 19
• Figure 7: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2007 20
• Figure 8: Forces Driving Competition in the OTC Pharmaceuticals Market in Brazil 21
• Figure 9: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Brazil 22
• Figure 10: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Brazil 23
• Figure 11: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Brazil 24
• Figure 12: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Brazil 26
• Figure 13: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Brazil 27
• Figure 14: Revenues & Profitability: Novartis AG 33
• Figure 15: Revenues & Profitability: GlaxoSmithKline PLC 37
• Figure 16: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 38
• Figure 17: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 39
• Figure 18: Russia OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 43
• Figure 19: Russia OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 44
• Figure 20: Russia OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 45
• Figure 21: Russia OTC Pharmaceuticals Market Share: % Share, by Value, 2007 46
• Figure 22: Forces Driving Competition in the OTC Pharmaceuticals Market in Russia 47
• Figure 23: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Russia 48
• Figure 24: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Russia 49
• Figure 25: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Russia 50
• Figure 26: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Russia 51
• Figure 27: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Russia 52
• Figure 28: Revenues & Profitability: Ranbaxy Laboratories Limited 54
• Figure 29: Revenues & Profitability: Zentiva NV 56
• Figure 30: Russia OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 59
• Figure 31: Russia OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 60
• Figure 32: India OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 64
• Figure 33: India OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 65
• Figure 34: India OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 66
• Figure 35: India OTC Pharmaceuticals Market Share: % Share, by Value, 2007 67
• Figure 36: Forces Driving Competition in the OTC Pharmaceuticals Market in India 68
• Figure 37: Drivers of Buyer Power in the OTC Pharmaceuticals Market in India 69
• Figure 38: Drivers of Supplier Power in the OTC Pharmaceuticals Market in India 70
• Figure 39: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in India 71
• Figure 40: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in India 73
• Figure 41: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in India 74
• Figure 42: Revenues & Profitability: Dabur India Limited 77
• Figure 43: Revenues & Profitability: Zandu Pharmaceutical Works Ltd 79
• Figure 44: Revenues & Profitability: Cipla Ltd 81
• Figure 45: India OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 82
• Figure 46: India OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 83
• Figure 47: China OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 87
• Figure 48: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 88
• Figure 49: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 89
• Figure 50: China OTC Pharmaceuticals Market Share: % Share, by Value, 2007 90
• Figure 51: Forces Driving Competition in the OTC Pharmaceuticals Market in China 91
• Figure 52: Drivers of Buyer Power in the OTC Pharmaceuticals Market in China 92
• Figure 53: Drivers of Supplier Power in the OTC Pharmaceuticals Market in China 93
• Figure 54: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in China 94
• Figure 55: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in China 95
• Figure 56: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in China 96
• Figure 57: Revenues & Profitability: Johnson & Johnson 101
• Figure 58: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 102
• Figure 59: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 103